全文获取类型
收费全文 | 138篇 |
免费 | 10篇 |
专业分类
儿科学 | 1篇 |
妇产科学 | 4篇 |
基础医学 | 17篇 |
临床医学 | 11篇 |
内科学 | 63篇 |
神经病学 | 19篇 |
特种医学 | 2篇 |
外科学 | 12篇 |
综合类 | 1篇 |
预防医学 | 3篇 |
药学 | 7篇 |
肿瘤学 | 8篇 |
出版年
2023年 | 4篇 |
2022年 | 5篇 |
2021年 | 10篇 |
2020年 | 3篇 |
2019年 | 7篇 |
2018年 | 9篇 |
2017年 | 3篇 |
2016年 | 5篇 |
2015年 | 1篇 |
2014年 | 1篇 |
2013年 | 3篇 |
2012年 | 4篇 |
2011年 | 8篇 |
2010年 | 3篇 |
2009年 | 7篇 |
2008年 | 9篇 |
2007年 | 14篇 |
2006年 | 7篇 |
2005年 | 10篇 |
2004年 | 7篇 |
2003年 | 3篇 |
2002年 | 1篇 |
2001年 | 2篇 |
2000年 | 3篇 |
1999年 | 2篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1992年 | 1篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1984年 | 3篇 |
1983年 | 1篇 |
1980年 | 1篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1970年 | 1篇 |
1947年 | 2篇 |
排序方式: 共有148条查询结果,搜索用时 15 毫秒
1.
Negro R Mangieri T Coppola L Presicce G Casavola EC Gismondi R Locorotondo G Caroli P Pezzarossa A Dazzi D Hassan H 《Human reproduction (Oxford, England)》2005,20(6):1529-1533
BACKGROUND: Infertile women positive for thyroid antibodies suffer from a poor pregnancy/delivery outcome, although conflicting data have been published. Our objective was to investigate if levothyroxine (LT4) exerts any effect on pregnancy and/or delivery rates in thyroid peroxidase antibody (TPOAb)-positive (+) women undergoing assisted reproductive technologies. METHODS: Patients undergoing treatment were screened for TPOAb, thyroid-stimulating hormone (TSH) and free thyroxine (FT4). A total of 72 (15%) out of the 484 euthyroid women selected were TPOAb (+). These 72 patients were randomly divided into two groups: group A (n = 36) underwent LT4 treatment, group B (n = 36) placebo. Group C consisted of 412 women (85%) who were TPOAb negative (-). All patients received controlled ovarian stimulation. The endpoints of treatment were pregnancy rate, miscarriage rate and delivery rate. RESULTS: No differences in pregnancy rate were observed between the three groups. Miscarriage rate was higher in TPOAb (+) in comparison to TPOAb (-) [relative risk: 2.01 (95% CI = 1.13-3.56), P = 0.028]. CONCLUSIONS: The pregnancy rate is not affected either by presence of TPOAb or treatment with LT4. However, TPOAb (+) women show a poorer delivery rate compared to TPOAb (-). LT4 treatment in TPOAb (+) does not affect the delivery rate. 相似文献
2.
Angiogenic response induced by acellular aortic matrix in vivo 总被引:2,自引:0,他引:2
Conconi MT Nico B Mangieri D Tommasini M di Liddo R Parnigotto PP Nussdorfer GG Ribatti D 《The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology》2004,281(2):1303-1307
In this study, we investigated the angiogenic response induced by acellular aortic matrices implanted in vivo onto the chick embryo chorioallantoic membrane (CAM), a useful model for such investigation. Results showed that acellular matrices were able to induce a strong angiogenic response comparable to that of fibroblast growth factor 2 (FGF-2), a well-known angiogenic cytokine. The angiogenic response was further increased when exogenous FGF-2 or transforming growth factor beta 1 (TGF-beta1) were added to the matrices and inhibited by the addition of an anti-FGF-2 or anti-TGF-beta1 antibodies. The response may be considered dependent on a direct angiogenic effect exerted by the matrices and in part also by the presence of FGF-2 and TGF-beta1 in the acellular matrices. 相似文献
3.
Nico B Paola Nicchia G Frigeri A Corsi P Mangieri D Ribatti D Svelto M Roncali L 《Neuroscience》2004,125(4):921-935
In order to ascertain whether the alterations of the blood-brain barrier (BBB) seen in adult dystrophic mdx-mice [Glia 42 (2003) 235], a human model of Duchenne muscular dystrophy (DMD), are developmentally established and correlated with other dystrophin isoforms which are localized at the glial-vascular interface, we used immunocytochemistry to investigate the expression of dystrophin isoforms (Dp71) during BBB development in mdx fetuses and in adult mice. Parallelly, we used Western blot, immunocytochemistry and immunogold electron microscopy to analyze the expression of the zonula occludens (ZO-1), aquaporin-4 (AQP4) and glial fibrillary acidic (GFAP) proteins as endothelial and glial markers, and we evaluated the integrity of the mdx BBB by means of intravascular injection of horseradish peroxidase (HRP). The results show reduced dystrophin isoforms (Dp71) in the mdx mouse compared with the control, starting from early embryonic life. Endothelial ZO-1 expression was reduced, and the tight junctions were altered and unlabeled. AQP4 and GFAP glial proteins in mdx mice also showed modifications in developmental expression, the glial vascular processes being only lightly AQP4- and GFAP-labeled compared with the controls. Confocal microscopy and HRP assays confirmed the alteration in vessel glial investment, GFAP perivascular endfoot reactivity being strongly reduced and BBB permeability increasing. These results demonstrate that a reduction in dystrophin isoforms (Dp71) at glial endfeet leads to an altered development of the BBB, whose no-closure might contribute to the neurological dysfunctions associated with DMD. 相似文献
4.
Pier Pasquale Leone Damiano Regazzoli Matteo Pagnesi Jorge Sanz-Sanchez Mauro Chiarito Francesco Cannata Nicolas M. Van Mieghem Marco Barbanti Corrado Tamburino Rui Teles Marianna Adamo Mizuki Miura Francesco Maisano Won-Keun Kim Francesco Bedogni Giulio Stefanini Antonio Mangieri Francesco Giannini Azeem Latib 《JACC: Cardiovascular Interventions》2021,14(11):1218-1228
ObjectivesThe aim of this study was to define predictors of prosthesis-patient mismatch (PPM) and its impact on mortality after transcatheter aortic valve replacement (TAVR) with self-expandable valves (SEVs) in patients with small annuli.BackgroundTAVR seems to reduce the risk for PPM compared with surgical aortic valve replacement, especially in patients with small aortic annuli. Nevertheless, predictors and impact of PPM in this population have not been clarified yet.MethodsPredictors of PPM and all-cause mortality were investigated using multivariable logistic regression analysis from the cohort of the TAVI-SMALL (International Multicenter Registry to Evaluate the Performance of Self-Expandable Valves in Small Aortic Annuli) registry, which included patients with severe aortic stenosis and small annuli (annular perimeter <72 mm or area <400 mm2 on computed tomography) treated with transcatheter SEVs: 445 patients with (n = 129) and without (n = 316) PPM were enrolled.ResultsIntra-annular valves conferred increased risk for PPM (odds ratio [OR]: 2.36; 95% confidence interval [CI]: 1.16 to 4.81), while post-dilation (OR: 0.46; 95% CI: 0.25–0.84) and valve oversizing (OR: 0.53; 95% CI: 0.28–1.00) seemed to protect against PPM occurrence. At a median follow-up of 354 days, patients with severe PPM, but not those with moderate PPM, had a higher all-cause mortality rate compared with those without PPM (log-rank p = 0.008). Multivariable Cox regression confirmed severe PPM as an independent predictor of all-cause mortality (hazard ratio: 4.27; 95% CI: 1.34 to 13.6).ConclusionsAmong patients with aortic stenosis and small aortic annuli undergoing transcatheter SEV implantation, use of intra-annular valves yielded higher risk for PPM; conversely, post-dilation and valve oversizing protected against PPM occurrence. Severe PPM was independently associated with all-cause mortality. 相似文献
5.
Valenzuela Cristian D. Levine Edward A. Mangieri Christopher W. Gawdi Rohin Moaven Omeed Russell Gregory Lundy Megan E. Perry Kathleen C. Votanopoulos Konstantinos I. Shen Perry 《Annals of surgical oncology》2022,29(6):3448-3449
Annals of Surgical Oncology - 相似文献
6.
Francesco Giannini MD Matteo Pagnesi MD Gianluca Campo MD PhD Michael Donahue MD Luca A. Ferri MD Carlo Briguori MD PhD Giulio G. Stefanini MD PhD Raffaele Scardala MD Gennaro Sardella MD Salvatore De Rosa MD PhD Filippo Figini MD Alberto Monello MD Luigi E. Pastormerlo MD Luca Testa MD PhD Annamaria Nicolino MD Alfonso Ielasi MD Alessandro Durante MD Angelo Leone MD Giorgios Tzanis MD Antonio Mangieri MD Giovanni Ciccarelli MD Martina Briani MD Bernhard Reimers MD Andrea Ceccacci MD Ciro Indolfi MD Imad Sheiban MD Cataldo Palmieri MD Francesco Bedogni MD Maurizio Tespili MD Azeem Latib MD Francesco Gallo Antonio Colombo MD 《Catheterization and cardiovascular interventions》2021,97(3):411-420
7.
Arif A. Khokhar BMBCh Alessandra Laricchia MD Francesco Ponticelli MD Won-Keun Kim MD Francesco Gallo Damiano Regazzoli MD Marco Toselli MD Alessandro Sticchi MD Rossella Ruggiero MD Alberto Cereda MD Adriana Zlahoda-Huzior MD Andrea Fisicaro MD Ilja Gardi MD Antonio Mangieri MD Bernhard Reimers MD Dariusz Dudek MD Antonio Colombo MD Francesco Giannini MD 《Catheterization and cardiovascular interventions》2021,98(3):595-604
8.
9.
10.